Bioavailability of Encapsulated Omega-3 Fatty Acids

NCT ID: NCT01940679

Last Updated: 2014-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-09-30

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Omega-3 fatty acids (n-3s), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have anti-inflammatory properties and other documented beneficial health effects that could warrant n-3 fortification of combat rations. However, military combat rations must meet rigorous shelf-stability guidelines (e.g.,, 3 years at 80°F or 6 months at 100°F), which is problematic for natural food sources of n-3s (e.g., oil and fish), which degrade when exposed to high temperatures and prolonged shelf-storage. Encapsulation, e.g., coating freeze dried n-3s with gelatin, can prevent this degradation, and Natick Soldier Research, Development and Engineering Center's (NSRDEC) Combat Feeding Directorate used encapsulated n-3 technology to produce n-3 enriched ration items that withstand environmental stressors and meet shelf-life specifications for military rations. However, the bioavailability of the encapsulated n-3s in these rations is unknown, particularly when they are incorporated into high-protein food items and exposed to high temperatures and prolonged storage. In this randomized, cross-over study, civilian and/or military personnel will be asked to consume: 1) a high protein food item enriched with encapsulated n-3s (600 mg) and previously stored for 6 months at 100°F; 2) a low-protein food item enriched with encapsulated n-3s (600 mg) and previously stored for 6 months at 100°F; 3) a high protein food item with encapsulated n-3s (600 mg) that was not subjected to high-temperature and prolonged storage; and, 4) a low-protein food item with encapsulated n-3s (600 mg) that was not subjected to high temperature and prolonged storage. Serial blood sampling to measure acute changes in the circulating fatty acid profile will occur in the hour before and 6 hours after consumption of each ration component. The only known risks, which this study presents to participants, are those associated with venous catheter placement. The results will help military ration developers determine the ration components best suited for n-3 fortification.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bioavailability of Omega-3s in Military Rations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fresh meat stick

Fresh meat stick w/ encapsulated 600 mg EPA/DHA; product frozen immediately after production.

Group Type EXPERIMENTAL

encapsulated 600 mg EPA/DHA

Intervention Type DIETARY_SUPPLEMENT

encapsulated 600 mg EPA/DHA

Stored meat stick

Stored meat stick with encapsulated 600 mg EPA/DHA; stored at 100F for 3 months after production

Group Type EXPERIMENTAL

encapsulated 600 mg EPA/DHA

Intervention Type DIETARY_SUPPLEMENT

encapsulated 600 mg EPA/DHA

Fresh pound cake

Fresh pound cake w/ encapsulated 600 mg EPA/DHA; product frozen immediately after production.

Group Type EXPERIMENTAL

encapsulated 600 mg EPA/DHA

Intervention Type DIETARY_SUPPLEMENT

encapsulated 600 mg EPA/DHA

Stored pound cake

Stored pound cake with encapsulated 600 mg EPA/DHA; stored at 100F for 3 months after production.

Group Type EXPERIMENTAL

encapsulated 600 mg EPA/DHA

Intervention Type DIETARY_SUPPLEMENT

encapsulated 600 mg EPA/DHA

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

encapsulated 600 mg EPA/DHA

encapsulated 600 mg EPA/DHA

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* between 18 and 45 years old
* leave status and have approval from your supervisor (for DoD Civilians)

Exclusion Criteria

* under the age of 18 or over the age of 45
* bleeding disorder (von Willebrand disease, hemophilia) or taking medications that impair ability to stop bleeding (heparin)
* consumed ≥1 serving (equivalent to a deck of cards) of salmon, herring, mackerel, anchovies, sardines, halibut or tuna or omega-3 enriched eggs per week over the previous past month
* regularly consume dietary supplements (for example, capsules) containing omega-3 fatty acids
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Combat Feeding Directorate at Natick Soldier, Research, Development and Engineering Center

UNKNOWN

Sponsor Role collaborator

United States Army Research Institute of Environmental Medicine

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tracey Smith

Research Dietitian

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tracey J Smith, PhD

Role: PRINCIPAL_INVESTIGATOR

U.S. Army Research Institute of Environmental Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

U.S. Army Research Institute of Environmental Medicine

Natick, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

13-13-H

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

An Evaluation of Omega-3 Fatty Acid
NCT03017651 COMPLETED PHASE1